VISTAGEN THERAPEUTICS, INC.

Company

Vistagen Therapeutics, Inc.

Filed

May 19, 2016

Accession Number

0000902664-16-007153

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →